ArticleNeurochemical research2010

Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease.

Hailin Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.